Pathogenesis of MALT lymphoma: implications for risk stratification and therapy.
Marcus
Robert
R
Department of Haematology, Addenbrookes Hospital, Cambridge, UK. robert.marcus@addenbrookes.nhs.uk
D020169:Caspases / Q000235:genetics; D002880:Chromosomes, Human, Pair 11; D002887:Chromosomes, Human, Pair 18; D020022:Genetic Predisposition to Disease; D016481:Helicobacter Infections / Q000150:complications; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000209:etiology* / Q000235:genetics / Q000628:therapy*; D000074884:Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; D009363:Neoplasm Proteins / Q000235:genetics; D012307:Risk Factors; D014178:Translocation, Genetic
D009363:Neoplasm Proteins; D020169:Caspases; C400109:MALT1 protein, human; D000074884:Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein